Empirical Asset Management, LLC
Position in AKBA — Akebia Therapeutics, Inc.
CIK 1926596
WELLESLEY, MA
Position in AKBA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$48,650
-$7,700 QoQ
Shares Held
35,000
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Empirical Asset Management, LLC holds $111,400 across 2 Drug Manufacturers - Specialty & Generic names. AKBA ranks #2 (43.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRON |
Cronos Group Inc.
|
25,000 | $62,750 | |
| 2 | AKBA |
Akebia Therapeutics, Inc.
This page
|
35,000 | $48,650 |
All Filings in AKBA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,650 | 35,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $56,350 | 35,000 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $54,600 | 20,000 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $19,200 | 10,000 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $25,270 | 13,300 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $44,484 | 33,700 | Shares | Sole | 2024-10-11 | |
| No filing history on record for this holder in this stock. | ||||||